BKIDC-1553, an orally active antiglycolytic agent and bumped kinase inhibitor-derived compound, has a predicted half-life of approximately 17 hours in humans. It inhibits CYP2C8 and Angiotensin Converting Enzyme, making it suitable for cancer research [1].
Molecular Weight:
389.45
CAS Number:
[1951431-34-7]
Formula:
C22H23N5O2
Target:
Angiotensin-converting Enzyme (ACE)
T85861
* VAT and and shipping costs not included. Errors and price changes excepted